Please wait...
Free, same-day prescription delivery to your doorstep is available in your area.
Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:
USARx offers the following ways to purchase this medication. Choose the Best option for you!
Nateglinide is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. nateglinide is not for treating type 1 diabetes.
Other diabetes medicines are sometimes used in combination with nateglinide if needed.
Nateglinide may also be used for purposes not listed in this medication guide.
You should not use nateglinide if you have diabetic ketoacidosis (call your doctor for treatment).
You should not use nateglinide if you are allergic to it, or if you have:
diabetic ketoacidosis (call your doctor for treatment).
Tell your doctor if you have ever had:
liver disease; or
gout.
Follow your doctor's instructions about using nateglinide if you are pregnant or you become pregnant. Controlling diabetes is very important during pregnancy, and having high blood sugar may cause complications in both the mother and the baby.
You should not breastfeed while using this medicine.
Nateglinide is not approved for use by anyone younger than 18 years old.
Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
Nateglinide is usually taken 3 times daily, within 1 to 30 minutes before a meal. If you skip a meal, do not take your dose of nateglinide. Wait until your next meal.
You may have low blood sugar (hypoglycemia) and feel very hungry, dizzy, irritable, confused, anxious, or shaky. To quickly treat hypoglycemia, eat or drink a fast-acting source of sugar (fruit juice, hard candy, crackers, raisins, or non-diet soda).
Your doctor may prescribe a glucagon injection kit in case you have severe hypoglycemia. Be sure your family or close friends know how to give you this injection in an emergency.
Also watch for signs of high blood sugar (hyperglycemia) such as increased thirst or urination.
Blood sugar levels can be affected by stress, illness, surgery, exercise, alcohol use, or skipping meals. Ask your doctor before changing your dose or medication schedule.
Nateglinide is only part of a treatment program that may also include diet, exercise, weight control, blood sugar testing, and special medical care. Follow your doctor's instructions very closely.
Store at room temperature away from moisture and heat.
Take your dose as soon as you can, but only if you are getting ready to eat a meal. If you skip a meal, skip the missed dose and wait until your next meal. Do not take two doses at one time.
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. You may have signs of low blood sugar, such as extreme weakness, blurred vision, sweating, trouble speaking, tremors, stomach pain, confusion, and seizure (convulsions).
Avoid drinking alcohol. It lowers blood sugar and may interfere with your diabetes treatment.
Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
seizure (convulsions); or
jaundice (yellowing of the skin or eyes).
Common side effects may include:
runny or stuffy nose, sneezing, cough, cold or flu symptoms;
diarrhea;
back pain;
dizziness; or
joint pain or stiffness.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Diabetes Type 2:
Initial dose: 60 to 120 mg orally 3 times a day before meals
Maintenance dose: 60 to 120 mg orally 3 times a day before meals
Comments:
-For patients who are near HbA1c goal when therapy is initiated, initial dose should be 60 mg orally 3 times.
-Patients should take this drug 1 to 30 minutes before a meal; if a meal is skipped, the dose scheduled to be given with that meal should be skipped to avoid hypoglycemia.
-This drug should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Use: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Nateglinide may not work as well when you use other medicines at the same time. Some drugs can also cause you to have fewer symptoms of hypoglycemia, making it harder to tell when your blood sugar is low. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all medicines you start or stop using.
Further informationRemember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.
Source: Drugs.com Nateglinide (www.drugs.com/mtm/nateglinide.html).
Applies to nateglinide: oral tablet
Side effects requiring immediate medical attentionAlong with its needed effects, nateglinide may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking nateglinide:
Less common
Check with your doctor as soon as possible if any of the following side effects occur while taking nateglinide:
Less common
Incidence not known-occurred during clinical practice
Some side effects of nateglinide may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Less common
For Healthcare Professionals
Applies to nateglinide: oral tablet
GeneralThe most frequently reported adverse events included upper respiratory tract infections and symptoms of hypoglycemia.
MetabolicCommon (1% to 10%): Hypoglycemia
Frequency not reported: Increases in mean uric acid level
Hypoglycemia has been reported and has generally been mild and corrected by intake of carbohydrates. In comparative clinical trials, hypoglycemia was reported in 10.4%, 14.5%, 6.9%, 19.8%, and 4.1% in patients receiving nateglinide alone, nateglinide plus metformin, metformin alone, glyburide alone, and placebo, respectively.
Mean uric acid levels were increased in patient receiving this drug as monotherapy. The difference from placebo in treated patients was 0.29 mg/dL, 0.45 mg/dL, 0.28 mg/dL, and 0.19 mg/dL in patients receiving nateglinide alone, nateglinide plus metformin, metformin alone, glyburide alone, respectively. The clinical significance of these findings is unknown.
RespiratoryCommon (1% to 10%): Upper respiratory tract infection, bronchitis, coughing
HypersensitivityPostmarketing reports: Hypersensitivity reactions such as rash, itching, and urticaria
GastrointestinalCommon (1% to 10%): Diarrhea, abdominal pain, dyspepsia, nausea
Uncommon (0.1% to 1%): Vomiting
Gastrointestinal symptoms, especially diarrhea and nausea, were no more common in patients using this drug in combination with metformin than in patients receiving metformin alone.
HepaticPostmarketing reports: Elevated liver enzymes, jaundice, cholestatic hepatitis
Nervous systemCommon (1% to 10%): Dizziness
MusculoskeletalCommon (1% to 10%): Back pain, arthropathy
CardiovascularFrequency not reported: Peripheral edema
Peripheral edema was no more common in patients using this drug in combination with rosiglitazone than in patients receiving rosiglitazone alone.
DermatologicPostmarketing reports: Erythema multiforme
ImmunologicCommon (1% to 10%): Flu symptoms
OtherCommon (1% to 10%): Accidental trauma
Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.
Source: Drugs.com Nateglinide (www.drugs.com/mtm/nateglinide.html).
August 6, 2020
August 6, 2020
October 19, 2020
October 19, 2020
October 19, 2020
October 19, 2020
